Efficacy of neoadjuvant imatinib in patients with gastrointestinal stromal tumours of the rectum

Trial Profile

Efficacy of neoadjuvant imatinib in patients with gastrointestinal stromal tumours of the rectum

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Imatinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Sep 2015 New trial record
    • 01 Jul 2015 Results published in the British Journal of Surgery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top